Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Bubs Australia Ltd. ( (AU:BUB) ) is now available.
Bubs Australia Limited has appointed Pascal De Petrini as a director, effective 24 April 2026, expanding its board with an experienced executive expected to support the company’s strategic direction in specialty nutrition markets. The initial director’s interest notice confirms that De Petrini currently holds no relevant interests in Bubs securities or related contracts, indicating his role begins without existing equity stakes, which may be relevant for governance and future incentive alignment.
This appointment underscores Bubs Australia’s ongoing board renewal and governance processes as it navigates competitive conditions in infant nutrition. Stakeholders may view the addition of a new director without current shareholdings as a neutral governance move, with future disclosures likely to clarify any subsequent equity-based incentives or contractual interests tied to company performance.
The most recent analyst rating on (AU:BUB) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Bubs Australia Ltd. stock, see the AU:BUB Stock Forecast page.
More about Bubs Australia Ltd.
Bubs Australia Limited is an Australian company operating in the food and nutrition sector, best known for its infant formula and baby food products targeting domestic and international markets. The company focuses on premium and specialty nutrition offerings aimed at health-conscious parents and export channels, particularly in Asia.
Average Trading Volume: 1,165,679
Technical Sentiment Signal: Sell
Current Market Cap: A$89.41M
See more data about BUB stock on TipRanks’ Stock Analysis page.

